secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001326110-25-000040
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio replaces auditor EY with Deloitte for fiscal year 2025
------------------------------------------------------------------

- Audit committee dismissed Ernst & Young as independent auditor on March 13, 2025; no disagreements or reportable events.
- Deloitte & Touche appointed as new independent auditor for fiscal year ending Dec 31, 2025, subject to client acceptance.
- EY provided a letter (Exhibit 16.1) agreeing with the company's disclosures in this 8-K.
- Company did not consult Deloitte on accounting principles during the two most recent fiscal years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000132611025000040/0001326110-25-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000132611025000040/ibrx-20250313.htm
  HTML page:      https://secwatch.observer/filing/0001326110-25-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer